Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CD86 |
| Upstream (Parents) |
|---|
| (<<) CD53 → CD86 |
| (<<) TFEC → CD86 |
| (<<) C3AR1 → CD86 |
| (<<) TYROBP → CD86 |
| Downstream (Children) |
|---|
| CD86 → CACNA1D (>>) |
| CD86 → TYMP (>>) |
| CD86 → DFNA5 (>>) |
| CD86 → DSE (>>) |
| CD86 → LILRB4 (>>) |
| CD86 → HLA-DRB4 (>>) |
| CD86 → TAAR3 (>>) |
| CD86 → IL21R (>>) |
| CD86 → HK3 (>>) |
| CD86 → HLA-DQA2///HLA-DQA1 (>>) |
| CD86 → TLR7 (>>) |
| CD86 → LAIR1 (>>) |
| CD86 → HLA-DMB (>>) |
| CD86 → LY96 (>>) |
| CD86 → MARCH1 (>>) |
| CD86 → CCR5 (>>) |
| CD86 → IFI30 (>>) |
| CD86 → TFEC (>>) |
| CD86 → HLA-DMA (>>) |
| CD86 → LAPTM5 (>>) |
| CD86 → FOXA2 (>>) |
| CD86 → FCER1G (>>) |
| CD86 → C3AR1 (>>) |
| CD86 → CLEC7A (>>) |
| CD86 → GLIPR1 (>>) |
